Pharmafile Logo
Pharmafocus logo
Advanced Search

Merck & Co

Showing 15 posts of 53 posts found.

Merck taps Parexel to help it meet biosimilar ambitions

January 18, 2011
Research and Development Merck & Co, Parexel, biosimilars

Merck & Co has enlisted the aid of contract research organisation Parexel to help it develop biosimilar versions of some …

News

Regulators fast-track Merck’s hepatitis C drug boceprevir

January 7, 2011
Sales and Marketing Merck & Co, boceprevir, hepatitis C, telaprevir

Merck’s new oral hepatitis C drug boceprevir will receive fast track reviews from both the FDA and the EMA after …

News

Merck acquires innovative insulin firm SmartCells

December 3, 2010
Research and Development Merck, Merck & Co, SmartCells, diabetes, insulin

Merck has bolstered its early stage diabetes portfolio with the acquisition of SmartCells, a private pharma firm that’s developing a …

News

New chief executive for Merck & Co

December 1, 2010
Manufacturing and Production, Research and Development, Sales and Marketing Kenneth Frazier, Merck, Merck & Co, Richard Clark, Schering-Plough

Kenneth Frazier is to be the next chief executive of Merck & Co from 1 January 2011 following his election …

News

Merck to develop new class of antibacterials

October 6, 2010
Research and Development BioRelix, Merck & Co, anti-infectives

Merck & Co has signed a drug development agreement with anti-infective pharma firm BioRelix to development a new class of …

News

Merck plans jobs cuts in Ireland

September 10, 2010
Manufacturing and Production Ireland, Merck & Co, Schering-Plough, job cuts

A manufacturing plant in Ireland is the latest to face staff cuts in the wake of Merck & Co’s merger …

News

Merck averts day in court over Dutch plant closure

September 7, 2010
Manufacturing and Production, Research and Development Merck & Co, Netherlands, job cuts

Merck & Co has postponed the planned closure of the former Organon facility in Oss, the Netherlands, after weeks of …

News

Merck wins double approval in Europe

September 3, 2010
Sales and Marketing Brinavess, Merck & Co, Syncrest, merck sharp and dohme

European regulators have given the green light for two of Merck & Co’s new drugs, licensing its anti-psychotic treatment Sycrest …

News

Merck signs Alzheimer’s deal with Alectos

August 16, 2010
Research and Development, Sales and Marketing Alzheimer's, Alzheimers, Merck & Co

Merck has entered a $289 million agreement with Canadian company Alectos Therapeutics in a bid to find new Alzheimer’s drugs. …

News

Pharma manufacturing news in brief

August 13, 2010
Manufacturing and Production Dutch CMO SynCo Bio Partners, GeoPharma, Merck & Co, Positron, SCM Pharma, Thermo Fisher Scientifitic

EMA and FDA issue call for volunteers for joint inspection pilot, plus facility updates from Merck & Co, Thermo Fisher …

News

Organon workers challenge Merck on Dutch facility closure

August 3, 2010
Manufacturing and Production, Research and Development Merck & Co, job cuts

Merck & Co’s decision to close down the former Organon facility in Oss, the Netherlands, looks set to be challenged …

News

Merck merger costs halve profits

August 2, 2010
Sales and Marketing 2010 financials, Merck & Co, Q2

Shares in Merck & Co fell as costs relating to the merger with Schering-Plough put a huge dent in second …

News

Manufacturing news in brief

July 20, 2010
Manufacturing and Production Apicore, Emergent, Merck & Co, PPS, Tianyin, lilly

A crop of facility announcements from Merck & Co, Emergent, Tianyin, Apicore and PPS offset more job loss news from …

News

Merck moves tropical disease drug into phase II

June 25, 2010
Research and Development Chagas disease, Merck & Co, Noxafil, tropical disease

Merck & Co is to see whether its oral antifungal agent Noxafil (posaconazole) can be used in chronic cases of …

News

Merck’s Brinavess performs in phase III

May 18, 2010
Research and Development Brinavess, Merck & Co, atrial fibrilation

Merck & Co’s heart disorder drug Brinavess has proved superior to rival amiodarone in reducing rates of atrial fibrillation in …

News
The Gateway to Local Adoption Series

Latest content

Five Facts about the menopause

March 6, 2026

Zello Appoints Kevin Bailey as Group Chief Medical Officer

March 6, 2026

BioDuro establishes joint manufacturing venture with Cenra

March 6, 2026

Symbiosis appoints Joanne Anderson as Chief Commercial Officer

March 6, 2026

Secarna Pharmaceuticals and Curie.Bio expand existing partnership

March 6, 2026